Evidence-based Nursing Practice in Surgical Clinics

May 12, 2025 updated by: Ezgi Arslan, Aydin Adnan Menderes University

Evaluation of Leadership and Work Environment in the Process of Integrating Evidence-based Practices in Surgical Clinics: A Multicenter Study

It is aimed to examine the leadership status and work environments of nurses working in surgical units during the integration of evidence-based practices into the institution.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The study will be conducted with 248 nurses working in surgical units of three centers in Aydın, Isparta and Burdur provinces. Before the data collection begins, nurses will be informed about the study. The study data will be collected by researchers through face-to-face interviews with nurses every weekday between 15:00-16:00, so that the daily operations of the nurses and the institution will not be affected. The purpose of the study will be explained to the nurses who will participate in the study and the nurses who volunteer to participate will be asked to fill out the form. The form will take approximately 15 minutes to fill out. The study will question the sociodemographic characteristics of the nurses, their leadership status in the process of integrating evidence-based practices into the clinic, and the work environment and influencing factors.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
248

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Aydın
      • Efeler, Aydın, Turkey, 09010
        • Ezgi Arslan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

It will be carried out in three centers in Aydın, Isparta and Burdur provinces with 248 nurses working in General Surgery, Urology, Orthopedics and Traumatology, ENT/Eye/Plastic and Reconstructive Surgery, Brain Surgery, Gynecology and Obstetrics, Pediatric Surgery and Day Surgery clinics, Surgical Intensive Care, General Intensive Care, Cardiovascular Intensive Care, Brain Surgery Intensive Care, Anesthesia Intensive Care, Emergency Service and Day Hospital, Operating Room Services.

Description

Inclusion Criteria:

  • Being over 18 years old
  • Having worked in a surgical unit for at least six months

Exclusion Criteria:

  • Not being a graduate of the nursing department

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Surgical nurses
It will be carried out with nurses working in the surgical units of Aydın Adnan Menderes University Practice and Research Hospital, the City Hospital and Süleyman Demirel University Research and Practice Hospital in Isparta province and Burdur State Hospital in Burdur province (General Surgery, Urology, Orthopedics and Traumatology, ENT/Eye/Plastic and Reconstructive Surgery, Brain Surgery, Gynecology and Obstetrics, Pediatric Surgery and Day Surgery clinics, Surgical Intensive Care, General Intensive Care, Cardiovascular Intensive Care, Brain Surgery Intensive Care, Anesthesia Intensive Care, Emergency Service and Day Hospital, Operating Room Service).

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Leadership in Evidence-Based Practice
Time Frame: Once between 01.10.2024 and 31.05.2025
This is the first section of the scale and consists of 10 items. Scale items are scored using a 5-point Likert system ranging from 1 (strongly disagree) to 5 (strongly agree). A minimum of 10 and a maximum of 50 points are obtained from the scale. As the score obtained from the scale increases, it is interpreted that leadership in evidence-based practices increases.
Once between 01.10.2024 and 31.05.2025
Evidence-Based Practice Work Environment
Time Frame: Once between 01.10.2024 and 31.05.2025
This is the second part of the scale and consists of 8 items. Scale items are scored using a 5-point Likert system ranging from 1 (strongly disagree) to 5 (strongly agree). A minimum of 8 and a maximum of 40 points are obtained from the scale. As the score obtained from the scale increases, it is interpreted that the working environment improves in evidence-based practices.
Once between 01.10.2024 and 31.05.2025

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Factors Affecting the Leadership and Work Environments of Surgical Nurses in the Process of Integration of Evidence-Based Practices into the Clinic
Time Frame: Once between 01.10.2024 and 31.05.2025
The effects of nurses' sociodemographic characteristics on primary outcomes will be examined.
Once between 01.10.2024 and 31.05.2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Aydin Adnan Menderes University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Sultan Özkan, PhD, Researcher
  • Study Director: Ezgi Arslan, PhD, Director
  • Study Chair: Filiz Salman Saraç, PhD, Researcher
  • Study Chair: Hatice Ersoy, PhD, Researcher

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 15, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 15, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 7, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 7, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 10, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 14, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 12, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Evidence-based Practice

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

IPD Sharing Time Frame

6 months after publication

IPD Sharing Access Criteria

Relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings